Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 6, 1998, Pages 320-325

  Haliotis, F A ^a   Papanastasiou, D A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Children; Iron hydroxide polymaltose complex; Iron protein succinylate; Sideropenia; Sideropenic anemia

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON POLYMALTOSE; IRON PROTEIN SUCCINYLATE;

ABDOMINAL PAIN; ANOREXIA; ANXIETY; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; FLUSHING; HEADACHE; HEARTBURN; HEMATOCRIT; HUMAN; INDIGESTION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; LASSITUDE; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NAUSEA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; VERTIGO; VOMITING;

ABDOMINAL PAIN; ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; DIARRHEA; DRUG TOLERANCE; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; FERRIC COMPOUNDS; HEMATINICS; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFANT; MALE; METALLOPROTEINS; NAUSEA; SUCCINATES; TREATMENT OUTCOME; VOMITING;

EID: 0031866220     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Baker SJ 1978 Nutritional anaemia: A major controllable health problem. Bull WHO 56: 659
2. Beghetti M, Mermillod B, Halperin DS 1993. Blue sclerae: a sign of iron deficiency anemia in children? Pediatrics 91: 1195-1196
3. Careddu P, Scotti A 1993 Controlled, double-blind, multicenter clinical trial of iron protein succinylate in the treatment of iron deficiency in children. Int J Clin Pharmacol Ther Toxicol 31: 157-169
4. Cremonesi P, Caramazza I 1993 Chemical and biological characterization of iron-protein succinylate (ITF 282). Int J Clin Pharmacol Ther Toxicol 31: 40-51
5. Dallman PR, Siimes PA 1979 Iron deficiency in infancy and childhood. International Nutrition Anemia Consultative group - The Nutrition WHO Foundation, New York and Washington
6. Jacobs P, Wormald L 1979 The bioavailability of an iron polymaltose complex for treatment of iron deficiency. J Med 10: 279-285
7. Jacobs P, Johnson G, Wood L 1984 Oral iron therapy in human subjects comparative absorption between ferrous salts and iron polymaltose. J Med 15: 367-377
8. Johnson G, Jacobs P 1990 Bioavailability and the mechanism of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals. Exp Hematol 18: 1064-1069
9. Kimber C, Weintraub LR 1968 Malabsorption of iron secondary to iron deficiency. N Engl J Med 279: 453-459
10. Köpke W, Sauerland MC 1995 Meta-analysis of efficacy and tolerability data on iron protein succinylate in patients with iron deficiency anemia of different severity. Arzneimittelforschung/Drug Res 45:1211-1216
11. Langstaff RJ, Geisser P, Heil WG, Bowdler JM 1993 Treatment of iron-deficiency anaemia: a lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate. Br J Clin Res 4: 191-198
12. Liguori L 1993 Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1.000 patients. Int J Clin Pharmacol Ther Toxicol 31: 103-123
13. Lozoff B 1994. Iron deficiency and infant development. J Pediatr 125: 577-578
14. Miller DR, Baehner RL 1989 Blood Diseases of Infancy and Childhood (6th edn). Mosby, Chicago, pp 170-198
15. Naiman JL, Oski FA, Diamond LK, Vawter GF, Shwachman H 1964 The gastrointestinal effects of iron-deficiency anemia. Pediatrics 33: 83-99
16. Nielsen P, Gabbe EE, Fischer R, Heinrich HC 1994 Bioavailability of iron from oral ferric polymaltose in humans. Arzneimittelforschung/Drug Res 44: 743-748
17. Oski M 1993 Iron deficiency in infancy and childhood. N Engl J Med 329: 190-193
18. Ozsoglu S, Ozbek N 1991 Bioavailability of iron. Exp Hematol 19: 1065-1216